Literature DB >> 26256463

Efficacy and Safety of Endoscopic Submucosal Dissection for Colorectal Carcinoids.

Tao Chen1, Li-Qing Yao1, Mei-Dong Xu1, Yi-Qun Zhang1, Wei-Feng Chen1, Qiang Shi1, Shi-Lun Cai1, Yin-Yin Chen2, Yan-Hong Xie3, Yuan Ji3, Shi-Yao Chen4, Ping-Hong Zhou5, Yun-Shi Zhong6.   

Abstract

BACKGROUND & AIMS: Although endoscopic submucosal dissection (ESD) of colorectal carcinoids is increasing, little is known about long-term outcomes of patients. We investigated the efficacy and safety of ESD of colorectal carcinoids and evaluated long-term outcomes, including local recurrence and metastasis.
METHODS: We performed a retrospective analysis of data collected from 239 consecutive patients with colorectal carcinoids <20 mm who underwent endoscopic ultrasonography (to evaluate the size of tumor and the depth of invasion), followed by ESD from January 2007 through October 2012 at the Zhongshan Hospital of Fudan University. Histology and patient data were collected during a median follow-up period of 52 months (range, 25-94 months) to determine tumor stage and type, completeness of resection, complications, tumor recurrence, and distant metastasis.
RESULTS: En bloc resection was achieved for all of the 239 treated lesions; tumor tissues were completely resected for 216 of the lesions (90.38%). Eight patients had ESD-related complications (3.35%). As more ESDs were performed by endoscopists, the rate of complete tumor resection increased, and the rate of complications decreased. ESD of carcinoids in colon increased the risk of non-R0 resection and the rate of complications. During the follow-up period, all patients remained free from local recurrence. However, distant metastases were detected in 6 patients (2.51%); lymphovascular invasion was a risk factor for metastasis.
CONCLUSIONS: ESD is effective for the resection of rectal carcinoids <20 mm and causes complications in less than 4% of patients. ESD for colonic carcinoids is feasible but associated with a higher non-R0 resection rate and a trend toward higher complications risk. Tumor features and stage determine risk for distant metastasis, so long-term follow-up is essential.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal Carcinoid; Endoscopic Submucosal Dissection; Therapy

Mesh:

Year:  2015        PMID: 26256463     DOI: 10.1016/j.cgh.2015.07.048

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  11 in total

1.  Efficacy and safety of additional surgery after non-curative endoscopic submucosal dissection for early colorectal cancer.

Authors:  Tao Chen; Yi-Qun Zhang; Wei-Feng Chen; Ying-Yong Hou; Li-Qing Yao; Yun-Shi Zhong; Mei-Dong Xu; Ping-Hong Zhou
Journal:  BMC Gastroenterol       Date:  2017-11-28       Impact factor: 3.067

Review 2.  Diagnosis and Management of Rectal Neuroendocrine Tumors.

Authors:  Shreya Chablaney; Zachary A Zator; Nikhil A Kumta
Journal:  Clin Endosc       Date:  2017-11-30

3.  Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumors.

Authors:  Cemal Yazici; Brian R Boulay
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

4.  Local surgical excision versus endoscopic resection for rectal carcinoid: A meta-analysis.

Authors:  Qiaoqi Sui; Junzhong Lin; Jianhong Peng; Yujie Zhao; Yuxiang Deng; Zhizhong Pan
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

5.  Resectability of Rectal Neuroendocrine Tumors Using Endoscopic Mucosal Resection with a Ligation Band Device and Endoscopic Submucosal Dissection.

Authors:  Hong Kyu Lim; Seong Jun Lee; Dong Hoon Baek; Do Youn Park; Bong Eun Lee; Eun Young Park; Joon Woo Park; Gwang Ha Kim; Geun Am Song
Journal:  Gastroenterol Res Pract       Date:  2019-09-16       Impact factor: 2.260

6.  Endoscopic resection is more effective than biopsy or EUS to detect residual rectal neuroendocrine tumor.

Authors:  Matthew W Stier; Christopher G Chapman; Steven Shamah; Kianoush Donboli; Lindsay Yassan; Irving Waxman; Uzma D Siddiqui
Journal:  Endosc Int Open       Date:  2021-01-01

Review 7.  Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance.

Authors:  Camilla Gallo; Roberta Elisa Rossi; Federica Cavalcoli; Federico Barbaro; Ivo Boškoski; Pietro Invernizzi; Sara Massironi
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

8.  A small, well-differentiated rectal neuroendocrine tumor with multiple lymph node metastases: A case report.

Authors:  Seung-Joo Nam; Gi Bong Chae; Seungkoo Lee; Sung Chul Park; Chang Don Kang; Sung Joon Lee
Journal:  Oncol Lett       Date:  2018-03-14       Impact factor: 2.967

9.  Long-term outcomes of endoscopic submucosal dissection for high-grade dysplasia and early-stage carcinoma in the colorectum.

Authors:  Tao Chen; Wen-Zheng Qin; Li-Qing Yao; Yun-Shi Zhong; Yi-Qun Zhang; Wei-Feng Chen; Jian-Wei Hu; Marie Ooi; Ling-Li Chen; Ying-Yong Hou; Mei-Dong Xu; Ping-Hong Zhou
Journal:  Cancer Commun (Lond)       Date:  2018-03-21

Review 10.  Efficacy and safety of endoscopic resection in treatment of small gastric stromal tumors: A state-of-the-art review.

Authors:  Ze-Ming Chen; Min-Si Peng; Li-Sheng Wang; Zheng-Lei Xu
Journal:  World J Gastrointest Oncol       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.